Cogent Biosciences, Inc.
COGT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$80,930 | -$73,529 | -$71,986 | -$67,927 |
| Dep. & Amort. | $1,147 | $1,157 | $1,138 | $1,158 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $9,716 | $10,008 | $0 |
| Change in WC | $4,760 | $7,835 | -$4,716 | -$1,131 |
| Other Non-Cash | $10,737 | $279 | -$955 | $7,323 |
| Operating Cash Flow | -$64,286 | -$54,542 | -$66,511 | -$60,577 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$65 | -$131 | -$547 | -$75 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$224,066 | -$67,883 | $0 | -$12,724 |
| Inv. Sales/Matur. | $69,085 | $76,924 | $69,926 | $74,470 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$155,046 | $8,910 | $69,379 | $61,671 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$235 | $47,222 | $0 | $0 |
| Stock Issued | $217,602 | $5 | $24,250 | $26 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $720 | $0 |
| Financing Cash Flow | $217,367 | $47,227 | $24,970 | $26 |
| Forex Effect | -$336 | $0 | $0 | $0 |
| Net Chg. in Cash | -$2,301 | $1,595 | $27,838 | $1,120 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $127,598 | $126,003 | $98,165 | $97,045 |
| End Cash | $125,297 | $127,598 | $126,003 | $98,165 |
| Free Cash Flow | -$64,351 | -$54,673 | -$67,058 | -$60,652 |